| US Composite: CEPH
Cephalon, Inc. is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. It manufactures medicate products in four therapeutic areas: Central Nervous System, Pain, Inflammatory Diseases and Oncology. Cephalon's products include NUVIGIL, TREANDA, AMRIX, FENTORA, PROVIGIL, TRISENOX, GABITRIL and ACTIQ. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.